Renal Denervation: 60 Second Insights
Published: 22 March 2019
-
Views:
5233 -
Likes:
7
-
Views:
5233 -
Likes:
7
-
Up Next
-
27sPart 13 | Session 4 Horst Sievert
-
26sPart 13 | Session 5 Ajay Kirtane
-
28sPart 13 | Session 6 Robert Schwartz
-
48sPart 1 | Session 1 Justin Davies Justin E Davies
-
40sPart 1 | Session 2 Aloke Finn Aloke V Finn
-
48sPart 1 | Session 3 David Kandzari
-
46sPart 1 | Session 4 Horst Sievert Horst Sievert
-
35sPart 1 | Session 5 Ajay Kirtane Ajay J Kirtane
-
41sPart 1 | Session 6 Robert Schwartz Robert S Schwartz
-
40sPart 2 | Session 1 Justin Davies Justin E Davies
-
38sPart 2 | Session 2 David Kandzari
-
17sPart 2 | Session 3 Horst Sievert Horst Sievert
-
33sPart 2 | Session 4 Ajay Kirtane Ajay J Kirtane
-
41sPart 2 | Session 5 Robert Schwartz Robert S Schwartz
-
55sPart 2 | Session 6 Patrick Serruys Patrick W Serruys
-
55sPart 2 | Session 7 Gerald Werner Gerald S Werner
-
25sPart 2 | Session 8 Aloke Finn Aloke V Finn
-
30sPart 3 | Session 1 Justin Davies Justin E Davies
-
35sPart 3 | Session 2 Aloke Finn Aloke V Finn
-
46sPart 3 | Session 3 David Kandzari
-
22sPart 3 | Session 4 Horst Sievert Horst Sievert
-
32sPart 3 | Session 5 Ajay Kirtane Ajay J Kirtane
-
42sPart 3 | Session 6 Robert Schwartz Robert S Schwartz
-
47sPart 4 | Session 1 Justin Davies Justin E Davies
-
22sPart 4 | Session 2 Aloke Finn Aloke V Finn
-
58sPart 4 | Session 3 David Kandzari
-
15sPart 4 | Session 4 Horst Sievert Horst Sievert
-
34sPart 4 | Session 5 Ajay Kirtane Ajay J Kirtane
-
33sPart 4 | Session 6 Robert Schwartz Robert S Schwartz
-
45sPart 5 | Session 1 Justin Davies Justin E Davies
-
24sPart 5 | Session 2 Aloke Finn Aloke V Finn
-
41sPart 5 | Session 3 David Kandzari
-
27sPart 5 | Session 4 Horst Sievert Horst Sievert
-
32sPart 5 | Session 5 Ajay Kirtane Ajay J Kirtane
-
42sPart 5 | Session 6 Robert Schwartz Robert S Schwartz
-
47sPart 5 | Session 7 Gerald Werner Gerald S Werner
-
36sPart 6 | Session 1 Justin Davies Justin E Davies
-
26sPart 6 | Session 2 Aloke Finn Aloke V Finn
-
51sPart 6 | Session 3 David Kandzari
-
30sPart 6 | Session 4 Horst Sievert Horst Sievert
-
39sPart 6 | Session 5 Ajay Kirtane Ajay J Kirtane
-
1m 1sPart 6 | Session 6 Robert Schwartz Robert S Schwartz
-
1m 7sPart 6 | Session 7 Gerald Werner Gerald S Werner
-
29sPart 7 Justin Davies Justin E Davies
-
23sPart 8 Justin Davies Justin E Davies
-
32sPart 9 | Session 1 Justin Davies Justin E Davies
-
1m 8sPart 9 | Session 2 David Kandzari
-
1m 12sPart 10 | Session 1 Justin Davies Justin E Davies
-
1m 18sPart 10 | Session 2 David Kandzari
-
54sPart 11 | Session 1 Justin Davies Justin E Davies
-
27sPart 11 | Session 2 Aloke Finn Aloke V Finn
-
54sPart 11 | Session 3 David Kandzari
-
29sPart 11 | Session 4 Horst Sievert Horst Sievert
-
33sPart 11 | Session 5 Ajay Kirtane Ajay J Kirtane
-
1m 1sPart 11 | Session 6 Robert Schwartz Robert S Schwartz
-
27sPart 12 | Session 1 Justin Davies Justin E Davies
-
31sPart 12 | Session 2 Aloke Finn Aloke V Finn
-
26sPart 12 | Session 3 David Kandzari
-
26sPart 12 | Session 4 Horst Sievert Horst Sievert
-
31sPart 12 | Session 5 Ajay Kirtane Ajay J Kirtane
-
49sPart 12 | Session 6 Robert Schwartz Robert S Schwartz
-
25sPart 13 | Session 1 Justin Davies Justin E Davies
-
21sPart 13 | Session 2 Aloke Finn Aloke V Finn
Overview
A short series of 60-second insight videos on renal denervation. Hear the expert views in under one minute!
More from this programme
Part 1
Thinking about patient preference, what role does RDN have in blood pressure control?
Part 2
What role do you see for renal denervation in control of blood pressure in your patients?
Part 3
Where does renal denervation fit in your current clinical practice?
Part 4
What are the biggest barriers to blood pressure control in your patients?
Part 5
Which patient groups are most receptive to RDN?
Part 6
What is needed to get widespread adoption into clinical practice?
Part 7
How have SPYRAL HTN-OFF and SPYRAL HTN-ON studies influenced your clinical practice?
1 session | |
Justin Davies | Watch now |
Part 8
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, what are the take-home messages for you?
1 session | |
Justin Davies | Watch now |
Part 9
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, for you, what are the key results?
2 sessions | |
Justin Davies | Watch now |
David Kandzari | Watch now |
Part 10
Can you give an overview of the RDN SPYRAL clinical trial program?
2 sessions | |
Justin Davies | Watch now |
David Kandzari | Watch now |
Part 11
Thinking about compliance, what are the advantages of RDN over pharmacological therapy?
Part 12
How does renal denervation work?
Part 13
Does renal denervation work?
Faculty Biographies